Reducing the cost: Advancing mRNA vaccines and therapeutics through IVT process development and scalable manufacturing
mRNA therapeutics can deliver genetic instructions directly into cells, enabling the production of any protein and the versatility of scalable platforms. Samsung Biologics has designed and developed a next-generation in vitro transcription platform that leverages data-driven design of experiments to consistently achieve high titers, improved purity, and low dsRNA levels.
Learn how we’re setting a new standard for scalable, high-quality mRNA production in the latest whitepaper.
mRNA therapeutics can deliver genetic instructions directly into cells, enabling the production of any protein and the versatility of scalable platforms. Samsung Biologics has designed and developed a next-generation in vitro transcription platform that leverages data-driven design of experiments to consistently achieve high titers, improved purity, and low dsRNA levels.
Learn how we’re setting a new standard for scalable, high-quality mRNA production in the latest whitepaper.
- CDO
- CGMP
- ADC
- Bio Campus
- IR
- CMO